Combined Versus Deep Serratus Anterior Plane Block Shows No Difference in VATS Postoperative Pain
A prospective randomized clinical trial at a single academic center enrolled 60 patients undergoing elective video-assisted thoracoscopic surgery (VATS). Patients were randomized to receive either a combined deep and superficial serratus anterior plane block (each injection of 15 mL 0.375% bupivacaine with epinephrine) or a deep serratus anterior plane block alone (30 mL of the same solution). All patients received additional local infiltration and standardized multimodal analgesia.
The primary outcome was not reported. Key secondary outcomes measured over 24 hours showed no statistically significant differences between groups. Total postoperative opioid consumption was 27.12 ± 16.67 mg morphine milligram equivalents in the deep block group versus 32.84 ± 19.86 mg in the combined block group (p = 0.137). Rescue analgesia requirements were 11.67 ± 11.47 mg versus 16.33 ± 12.45 mg (p = 0.141). Postoperative pain scores were similar (p > 0.05).
Safety assessment found the incidence of opioid-related adverse effects was similar between groups, with both techniques offering comparable safety profiles. Serious adverse events and discontinuations were not reported.
Key limitations include the single-center design, modest sample size of 60 patients, and lack of reported primary outcome. The study cannot claim superiority of either technique and findings may not generalize beyond VATS populations or different block protocols. For practice, a single deep serratus anterior plane block appears to provide equivalent postoperative analgesia to a combined approach in this specific surgical setting when used with supplemental local infiltration and multimodal analgesia.